About this Abstract |
| Meeting |
2027 TMS Annual Meeting & Exhibition
|
| Symposium
|
Functional Nanomaterials 2027
|
| Presentation Title |
Defect-Engineered Cerium Oxide Nanoparticles for Reactive Oxygen Species-Mediated Antibacterial Therapy |
| Author(s) |
Ikhazuagbe Hilary Ifijen, Oluwaseyi Bukky Ovonramwen , Ukeme D Archibong |
| On-Site Speaker (Planned) |
Oluwaseyi Bukky Ovonramwen |
| Abstract Scope |
The rapid emergence of multidrug-resistant bacteria has intensified the search for alternative antimicrobial strategies beyond conventional antibiotics. Defect-engineered cerium oxide (CeO₂) nanoparticles have attracted considerable attention owing to their tunable redox properties, oxygen vacancy-rich structures, and ability to modulate reactive oxygen species (ROS) generation. This study highlights recent advances in oxygen vacancy engineering as an effective approach for enhancing the antibacterial activity of CeO₂ nanoparticles. The role of defect-induced Ceł⁺/Ce⁴⁺ redox cycling in promoting ROS generation, membrane disruption, oxidative biomolecular damage, and bacterial cell death is critically discussed. The influence of particle size, morphology, surface chemistry, and defect concentration on antibacterial performance is examined alongside current strategies for improving catalytic activity and selectivity. Finally, key challenges associated with biosafety, defect stability, and clinical translation are identified, providing perspectives for the rational design of next-generation cerium oxide nanoantibiotics against drug-resistant bacterial infections. |
| Proceedings Inclusion? |
Planned: |
| Keywords |
Other, Sustainability, Biomaterials |